Nuanced Health
Nuanced Health Employees
13 people indexed:
-
Antonio Carmona
Research Associate
-
3462q@gv2kpjg2xvvvs.w05 Sign up to see email
-
Claire Winter
Research Support Technician
-
Cuong Nguyen
Senior Scientist
-
Greg Fedewa
Bioinformatics Scientist
-
rkp74x5.06zb1@912qvz3807b7z.wx9 Sign up to see email
-
Leslie Sedgeman
Scientist
-
Miriam Velez
Research Associate
-
75z510@y0z2wwq6skyqj.9qx Sign up to see email
-
3v4gir.zs6@p2gv43byb04i9.qks Sign up to see email
-
9b0q59@gwff869p6177x.ygx Sign up to see email
-
William Randall
Chief of Staff
-
b3b.z25q@63p0irq2804kk.jzi Sign up to see email
Nuanced Health's Founding
Nuanced Health was founded in 2021 with the mission to empower drug discovery by supercharging in vivo data generation for preclinical drug development. The company is based in Los Angeles, CA, specifically at 1927 Paseo Rancho Castilla Drive. Despite being a relatively new player in the biotech industry, Nuanced Health has quickly established itself as a pioneer in the realm of preclinical drug development, focusing on understanding and leveraging environmental drivers of health and disease.
Nuanced Health's Technology
At the core of Nuanced Health's innovation is its revolutionary drug development technology that systematically humanizes the mouse microbiome. This groundbreaking approach enables the creation of next-generation preclinical models that accurately mimic the heterogeneity of human populations. By humanizing the mouse microbiome, Nuanced Health can generate high-resolution multi-omic datasets at an unprecedented scale, providing invaluable insights for drug discovery and development.
Nuanced Health's Data and Scale
Nuanced Health has made significant strides in generating and analyzing massive amounts of data to support drug discovery. The company has transplanted over 50 human microbiomes and has more than 3,000 humanized mice currently under study. This extensive research has resulted in the collection of over 80,000 phenotypic data points and the analysis of more than 50,000 multi-omic datasets. Such data-rich initiatives are crucial for understanding the complex interactions between genetics, environment, and disease.
Nuanced Health's Investors
Nuanced Health has garnered substantial support from a variety of top-tier investors, reflecting confidence in its innovative approach to drug development. The lead investment comes from 8VC, with additional backing from co-investors such as Freeflow, Gaingels, Open Field Capital, Heritage Group, Luma Bio-IT SPV, Presight Capital, Axial, and January River. This robust financial support enables Nuanced Health to continue its cutting-edge research and development efforts, pushing the boundaries of what is possible in preclinical drug development.
Nuanced Health's Impact
By focusing on the environmental drivers of health and disease, Nuanced Health is poised to make significant contributions to the field of drug discovery. The company’s ability to recreate the heterogeneity of human populations in preclinical models holds promise for more accurate and effective drug development. The high-resolution multi-omic datasets generated by Nuanced Health provide a wealth of information that can lead to novel insights and therapeutic breakthroughs, ultimately aiming to improve patient outcomes and advance our understanding of complex diseases.